Michael H. Silverman

Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis

Animesh Pardanani, Jason Gotlib, Catriona Jamieson et al. · Journal of Clinical Oncology · 2011 · 395 citations · Full text

ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia

Francisco García, Karl Ulrich Petry, Laila I. Muderspach et al. · Obstetrics and Gynecology · 2004 · 188 citations

Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.

Michael H. Silverman, Vibeke Strand, Doron Markovits et al. · PubMed · 2008 · 132 citations

Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform

Allan J. Pantuck, Dong‐Keun Lee, Theodore Kee et al. · Advanced Therapeutics · 2018 · 120 citations

Urology, Artificial Intelligence Platform, Medicine +11

Pilot Trial of Cyclosporine 1% Ophthalmic Ointment in the Treatment of Keratoconjunctivitis Sicca

Robert Laibovitz, Suzanne Solch, Kim Andriano et al. · Cornea · 1993 · 111 citations

Cyclosporine 1, Pilot Trial, Ocular Disease +10